Pre-extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in Ethiopia: a laboratory-based surveillance study

[1]  Y. Pang,et al.  Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition , 2021, Antimicrobial Resistance & Infection Control.

[2]  A. Bañuls,et al.  Resistance to Second-Line Anti-TB Drugs in Cambodia: A Phenotypic and Genetic Study , 2021, Infection and drug resistance.

[3]  K. Desta,et al.  The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment initiating centers in Ethiopia , 2021, PloS one.

[4]  Sarman Singh,et al.  Performance of Genotype MTBDRsl V2.0 over the Genotype MTBDRsl V1 for detection of second line drug resistance: An Indian perspective , 2020, PloS one.

[5]  B. Tessema,et al.  The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia , 2020, PloS one.

[6]  Jianyong Zhang,et al.  Drug resistance profiles and trends in drug-resistant tuberculosis at a major hospital in Guizhou Province of China , 2019, Infection and drug resistance.

[7]  S. Hossain,et al.  gyrA Gene Mutation Conferring Phenotypic Cross-Resistance among Fluoroquinolones (Ofloxacin, Levofloxacin and Gatifloxacin) in Multidrug Resistant Mycobacterium tuberculosis Strains Isolated from Pulmonary MDR-TB Patients in Bangladesh , 2018 .

[8]  Liang Chen,et al.  Evaluation of the GenoType MTBDRplus and MTBDRsl for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Beijing, China , 2018, bioRxiv.

[9]  J. Kosterink,et al.  In Vitro Susceptibility of Mycobacterium tuberculosis to Amikacin, Kanamycin, and Capreomycin , 2018, Antimicrobial Agents and Chemotherapy.

[10]  F. Brossier,et al.  Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains , 2016, Journal of Clinical Microbiology.

[11]  Pooja Singh,et al.  A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India , 2016, The Indian journal of medical research.

[12]  Tiantuo Zhang,et al.  Molecular Characterization of Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Strains in Jiangxi, China , 2012, Journal of Clinical Microbiology.

[13]  W. Xia,et al.  Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China. , 2012, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[14]  V. Jarlier,et al.  Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study. , 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[15]  U. Desai,et al.  Prevalence of Pre-Extensively Drug-Resistant Tuberculosis ( Pre XDR-TB ) and Extensively Drug-Resistant Tuberculosis ( XDR-TB ) among Pulmonary Multidrug Resistant Tuberculosis ( MDR-TB ) at a Tertiary Care Center in Mumbai , 2016 .

[16]  M. Zignol,et al.  Guidelines for surveillance of drug resistance in tuberculosis , 2015 .

[17]  T. Victor,et al.  Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.